Literature DB >> 8641342

Inhibition of human erythroid colony-forming units by interferons alpha and beta: differing mechanisms despite shared receptor.

R T Means1, S B Krantz.   

Abstract

Previous investigations have demonstrated that interferons alpha, beta, and gamma (alpha-, beta-, and gamma-IFN) are potent inhibitors of erythropoiesis in vitro. By utilizing a cell population enriched for human erythroid colony-forming units (CFU-E), we have previously demonstrated that the inhibitory effects of beta- and gamma-IFNs are direct effects, not requiring the presence of accessory cells, and that the inhibitory effect of recombinant human (rh) gamma-IFN could be corrected by high concentrations of rh erythropoietin (Epo). In this study, we compared the effects of rh(alpha)-IFN on cells enriched for CFU-E to its effects on unpurified marrow cells and found that although h(beta)-IFN (which shares a common receptor with alpha-IFN) directly inhibits CFU-E colony formation, the effect of rh(alpha)-IFN is indirect and is mediated by a soluble factor released from T lymphocytes in response to rh(alpha)-IFN. However, rh(alpha)-IFN enhanced the direct inhibitory effect of rh(gamma)-IFN on CFU-E not inhibited by rh(alpha)-IFN. The inhibitory effects of neither alpha- nor beta-IFN could be overcome by high levels of rhEpo. These findings imply that alpha- and beta-IFN exert different cellular effects despite binding to the same receptor. Failure of rhEpo to correct CFU-E colony inhibition by alpha- and beta-IFNs but not by gamma-IFN also suggests a mechanism for the differing degrees of response to different doses of rhEpo in patients with the anemia of chronic disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8641342

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  8 in total

1.  Lupeol, a triterpenoid isolated from Calotropis gigantea latex ameliorates the primary and secondary complications of FCA induced adjuvant disease in experimental rats.

Authors:  Venkatesan Saratha; Sorimuthu Pillai Subramanian
Journal:  Inflammopharmacology       Date:  2011-10-16       Impact factor: 4.473

2.  Pregnancy-secreted Acid phosphatase, uteroferrin, enhances fetal erythropoiesis.

Authors:  Wei Ying; Haiqing Wang; Fuller W Bazer; Beiyan Zhou
Journal:  Endocrinology       Date:  2014-08-05       Impact factor: 4.736

3.  Mammalian target of rapamycin (mTOR) inhibitors: potential uses and a review of haematological adverse effects.

Authors:  Sofia Sofroniadou; David Goldsmith
Journal:  Drug Saf       Date:  2011-02-01       Impact factor: 5.606

4.  Inflammation, T-cell phenotype, and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy.

Authors:  Elísio Costa; Margarida Lima; João Moura Alves; Susana Rocha; Petronila Rocha-Pereira; Elisabeth Castro; Vasco Miranda; Sameiro Faria Maria do; Alfredo Loureiro; Alexandre Quintanilha; Luís Belo; Alice Santos-Silva
Journal:  J Clin Immunol       Date:  2008-05       Impact factor: 8.317

5.  STAT6-mediated suppression of erythropoiesis in an experimental model of malarial anemia.

Authors:  Neeta Thawani; Mifong Tam; Mary M Stevenson
Journal:  Haematologica       Date:  2008-12-23       Impact factor: 9.941

6.  Different effects of rat interferon alpha, beta and gamma on rat hepatic stellate cell proliferation and activation.

Authors:  Hong Shen; Manna Zhang; Gerald Y Minuk; Yuewen Gong
Journal:  BMC Cell Biol       Date:  2002-04-08       Impact factor: 4.241

7.  Integrative analysis associates monocytes with insufficient erythropoiesis during acute Plasmodium cynomolgi malaria in rhesus macaques.

Authors:  Yan Tang; Chester J Joyner; Monica Cabrera-Mora; Celia L Saney; Stacey A Lapp; Mustafa V Nural; Suman B Pakala; Jeremy D DeBarry; Stephanie Soderberg; Jessica C Kissinger; Tracey J Lamb; Mary R Galinski; Mark P Styczynski
Journal:  Malar J       Date:  2017-09-22       Impact factor: 2.979

8.  Delta-Globin Gene Expression Is Enhanced in vivo by Interferon Type I.

Authors:  Maria Francesca Manchinu; Michela Simbula; Cristian Antonio Caria; Ester Musu; Lucia Perseu; Susanna Porcu; Maristella Steri; Daniela Poddie; Jessica Frau; Eleonora Cocco; Laura Manunza; Susanna Barella; Maria Serafina Ristaldi
Journal:  Front Med (Lausanne)       Date:  2020-05-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.